| Trial Identifier: | D9230C00002 |
| Sponsor: | AstraZeneca |
| Start Date: | March 2023 |
| Primary Completion Date: | March 2024 |
| Study Completion Date: | March 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Spanish Translation |
| Country | Location |
|---|---|
| US, AZ | Chandler, AZ, US, 85224 |
| US, CA | Montclair, CA, US, 91763 |
| US, FL | Hialeah, FL, US, 33016 |
| US, FL | Port Orange, FL, US, 32127 |
| US, GA | Atlanta, GA, US, 30349 |
| US, NC | Morehead City, NC, US, 28557 |
| US, PR | San Juan, PR, US, 00927 |
| US, TX | Houston, TX, US, 77079 |
| US, TX | San Antonio, TX, US, 78215 |
| US, TX | San Antonio, TX, US, 78229 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company